Home » Newsletters » BioWorld

BioWorld

Sep. 7, 2004

View Archived Issues

World's Largest Nation Drawing Attention From Biotech, Pharma

States Angling To Control Reimportation, Stem Cells

Holiday Notice

BioWorld Today's offices are closed Monday, Sept. 6, in observance of Labor Day. No issue will be published. Read More

Other News To Note

MediciNova $44M Financing To Advance Products To Phase II

As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today) Read More

NeoPharm's Kapoor Makes Bid To Change Board, Reduce Costs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...